SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

AstraZenecas reported Baxfendy sales have traders questioning how quickly the new aldosterone-inhibitor class can gain coverage and commercial traction, weighing on expectations for Mineralys planned launch. Some see the early sales as a normal reimbursement ramp for a chronic treatment, while others worry that a slow launch and competition could constrain lorundrostats sales potential.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of Voceryq, a competing treatment for recurrent respiratory papillomatosis, has put pressure on Precigens PAPZIMEOS and raised concerns about competition. Traders debate the threat to Precigens sales against its first-mover and full-approval advantages, while noting Voceryqs accelerated-approval status and commercialization hurdles.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is drawing attention after Piper Sandler lowered its price target, keeping a Neutral rating while pointing to concerns that networking growth may be peaking and valuations could compress. Traders are debating whether the selloff is justified or an overreaction, with bulls pointing to continued AI-infrastructure demand and bears focused on weak price action.

Zebec Network (ZBCN) is a cryptocurrency launched in 2022and operates on the Solana platform. Zebec Network has a current supply of 99,998,768,617.445403. The last known price of Zebec Network is 0.00204055 USD and is down -0.09 over the last 24 hours. It is currently trading on 133 active market(s) with $10,537,951.06 traded over the last 24 hours. More information can be found at https://zebec.io/.

Zebec Network

Traders are focused on reported MoneyGram connectivity and Zebecs broader payroll and payments expansion, viewing real-world adoption and potential token demand as bullish catalysts. Others remain skeptical, pointing to weak price follow-through and questioning whether business growth will translate into sustained ZBCN usage or buybacks.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Positive Phase 3 data for Amgens IMDELLTRAImfinzi combination in small-cell lung cancer is supporting bullish attention as shares reach a fresh high, with traders also focused on the upcoming earnings report and a Sjgrens disease readout. Put-heavy options activity is being debated as possible earnings hedging rather than a clear bearish bet, alongside call buying and momentum interest.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIMs attention is centered on its higher full-year outlook, which traders link to persistently strong container freight rates and demand, boosting expectations for earnings and dividends. The community is also debating whether Hapag-Lloyds acquisition can clear Israeli regulatory objections, with some favoring a sale and others preferring standalone cash generation and dividends.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a 52-week high ahead of the expected Q3 report has traders focused on BRIUMVIs sales momentum, while unconfirmed buyout speculation and call-heavy options activity add to the buzz. The community is split on whether the rally reflects earnings positioning and potential short covering or anticipation of a deal; no buyout has been confirmed.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devons agreed sale of its Eagle Ford assets to Crescent is driving attention, following earlier speculation about asset divestitures and pressure to streamline the company after its Coterra merger. Traders are divided on whether the sale improves focus and capital allocation, with some questioning why the shares have not responded more strongly.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders react to a sharp tech-led Nasdaq selloff and falling futures, with worries about AI spending returns and disappointing tech results reinforcing bearish bets. Many are buying or holding SQQQ as a hedge, while others warn that the leveraged ETF can reverse quickly; separate Iran-deal chatter remains unverified and contested.

3M Co. is a technology company, which engages in manufacturing industrial, safety, and consumer products. It operates through the following segments: Safety and Industrial, Transportation and Electronics, Consumer, and Corporate. The Safety and Industrial segment consists of personal safety, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules. The Transportation and Electronics segment includes electronics, automotive and aerospace, commercial solutions, advanced materials, and transportation safety. The Consumer segment covers consumer healthcare, home care, home improvement, and stationery and office products, such as consumer bandages, braces, supports, respirators, cleaning products, retail abrasives, picture hanging, and consumer air quality solutions. The Corporate segment refers to special items and other corporate expenses. The company was founded by Henry S. Bryan, Hermon W. Cable, John Dwan, William A. McGonagle, and J. Danley Budd in 1902 and is headquartered in St. Paul, MN.

3M Co.

3Ms earnings beat and raised outlook, alongside its expanded Amazon data-center partnership, are driving attention. Bulls see the deal as a growth opportunity, while skeptics note that Amazons purchase threshold is conditional and call the rally overdone, with bearish traders discussing puts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Edwards' Q3 Earnings on the Horizon: What's in the Cards?

EW heads into Q3 with TAVR momentum, expanding mitral and tricuspid therapies and surgical heart growth. Can it beat earnings estimates?

Curious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Edwards Lifesciences (EW), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2026.

ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?

PDEX heads into fiscal Q1 earnings with strong medical-device sales and margin momentum, but customer concentration, a shrinking backlog and acquisition risks loom.

SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?

SYK's Q3 earnings may reflect strong hospital equipment demand and cybersecurity recovery, but supply constraints, vascular disruptions and margin pressures remain.

WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?

WST's Q3 earnings may benefit from strong HVP demand, biologics and GLP-1 growth, but West Vantage weakness and the SmartDose divestiture could weigh on sales.

GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?

GEHC heads into Q3 earnings with strong imaging demand and a record backlog, but PCS weakness, inflation and supply challenges could weigh on margins.

$100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 1.24% on an annualized basis producing an average annual return of 14.27%. Currently, Edwards Lifesciences has a market capitalizationread more...

INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?

Inspire Medical Systems gains 47.8% in three months as improved reimbursement clarity, an earnings beat, $30 million in annual savings and new CPT codes boost recovery prospects.

DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally?

DaVita's 55.6% stock rally reflects stronger operating execution, improving treatment volumes and value-based kidney care gains despite reimbursement pressures.

BDX Stock Gains 25.5% in Six Months: What's Behind the Rally?

BD's 25.5% rally reflects stronger execution, portfolio reshaping, product innovation and U.S. manufacturing investments despite tariffs and cost pressures.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Edwards Lifesciences Corp

Nvidia, Citi, AT&T, Lucid, Edwards Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks?

Equity

Bearish Sentiment

The&nbsp;benchmark&nbsp;S&amp;P 500 index fell for a fifth straight day on Thursday,&nbsp;with new&nbsp;data showing strong private sector activity and extended tech weakness&nbsp;sapping risk appetite.After the market closed, the following stocks saw brisk trading volumes in the extended session:Nvidia Corp. (NVDA)After-hours move: -0.10%Trading volume: 8.83 million<a href="https://stocktwits.com/symbol/NVDA">Nvidia stock,</a> which fell only modestly in Thursday’s extended session, steepened its losses in overnight trading after reports said the Jensen Huang-led company told component suppliers to suspend orders related to its H20 artificial intelligence (AI) chip&nbsp;for the Chinese market. Huang is reportedly in Taipei to visit foundry partner TSMC (TSM), and he told reporters that the company was in discussions with&nbsp;U.S. lawmakers&nbsp;regarding a successor to the H20 chips.Retail traders on Stocktwits were divided over the stock trajectory, although the overall sentiment toward the stock remained ‘bullish’ and the message volume was at ‘normal’ levels.<figure class="image"><img style="aspect-ratio:617/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_22_at_1_33_05_AM_png_48f99a10d9.webp" alt="Screenshot 2025-08-22 at 1.33.05 AM.png" width="617" height="53"><figcaption>NVDA sentiment and message volume as of 1:30 a.m. ET, Aug. 22 | source: Stocktwits</figcaption></figure>Some rooted for the stock to cross the $200 level after next week’s earnings, while others saw risk stemming from the developments on AI chip exports to China.Nvidia’s stock has gained over 30% this year.Citigroup, Inc. (C)After-hours move: +0.22%Trading volume: 8.05 millionInvestment and banking giant Citigroup&nbsp;was on investors’ radar&nbsp;sans a notable catalyst. The stock pulled back 0.62% in Thursday’s regular session,&nbsp;even as volumes&nbsp;were below average.Financial stocks&nbsp;broadly are in the spotlight as the Federal Reserve is widely expected to cut&nbsp;interest rates in September. More clarity on the rate outlook&nbsp;would emerge when Fed Chair Jerome Powell takes the podium at the Jackson Hole conference on Friday.Separately, the company recently&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-08-20/citi-investigates-hr-complaints-against-wealth-head-andy-sieg">hired</a> law firm Paul Weiss to investigate complaints about its Wealth Management chief, Andy Sieg.&nbsp;On Stocktwits, sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/C">Citi stock</a> remained ‘bullish’ (55/100) by late Thursday and the message volume, however, was at ‘low’ levels.<figure class="image"><img style="aspect-ratio:615/56;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_22_at_1_32_09_AM_png_0990996887.webp" alt="Screenshot 2025-08-22 at 1.32.09 AM.png" width="615" height="56"><figcaption>C sentiment and message volume as of 1:30 a.m. ET, Aug. 22 | source: Stocktwits</figcaption></figure>Citi’s stock is up more than 34% so far this year.AT&amp;T, Inc. (T)After-hours move: +0.14%Trading volume: 6.36 millionTelecom giant&nbsp;<a href="https://stocktwits.com/symbol/T">AT&amp;T’s stock</a> rose to a fresh high on Thursday amid increasing investor optimism about the company’s prospects in a challenging macro climate. FOMO (fear-of-missing-out) hit investors as they weighed in on potential opportunities such as&nbsp;the&nbsp;5G infrastructure buildout.Retail investors on Stocktwits called the stock a “safe haven,” while some said “time to cash out” following six straight sessions of gains.In a&nbsp;note released Wednesday, BofA Securities&nbsp;stated it was adding AT&amp;T to its “US 1 List,” a collection of the firm’s best investment ideas drawn from&nbsp;its&nbsp;Buy-rated stocks.The sentiment meter read 68/100 for AT&amp;T stock, suggesting a ‘bullish’ mood, and the message volume picked up, although to ‘normal’ levels.<figure class="image"><img style="aspect-ratio:612/50;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_22_at_1_30_46_AM_png_0627312bf6.webp" alt="Screenshot 2025-08-22 at 1.30.46 AM.png" width="612" height="50"><figcaption>T sentiment and message volume as of 1:30 a.m. ET, Aug. 22 | source: Stocktwits</figcaption></figure>The stock has gained nearly 34% so far this year.Lucid Group, Inc. (LCID)After-hours move: +0.48%Trading volume: 4.42 millionLuxury electric-vehicle maker Lucid Group’s shares fell over 8% on Thursday. After the market closed, the company announced the effective&nbsp;date of&nbsp;its 1-for-10 reverse stock split, which shareholders had approved on Aug. 18.&nbsp;The split-adjusted stock will begin trading on Sept. 2.Retail sentiment toward the stock stayed ‘bearish’ (35/100), accompanied by ‘low’ message volume.<figure class="image"><img style="aspect-ratio:616/48;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_22_at_1_29_50_AM_png_95022d150d.webp" alt="Screenshot 2025-08-22 at 1.29.50 AM.png" width="616" height="48"><figcaption>LCID sentiment and message volume as of 1:30 a.m. ET, Aug. 22 | source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/LCID">Lucid stock</a> has declined about 31% this year&nbsp;amid weakness in its business and the broader EV market.Edward Lifesciences, Inc. (EW)After-hours move: -0.20%Trading volume: 3.55 millionThe shares of the&nbsp;med-tech company, whose products and services treat advanced cardiovascular diseases, snapped their six-session winning streak on Thursday. The recent upward momentum was&nbsp;driven by the company’s announcement of a new $500-million share buyback plan.The stock, which hit a new 52-week high of $83 in late July, ended Thursday at $81.16.<a href="https://stocktwits.com/symbol/EW">Edwards Lifesciences stock</a> has continued to elicit ‘bullish’ sentiment (66/100)&nbsp;among retail investors on the Stocktwits platform, although the message volume has stayed at ‘low’ levels.<figure class="image"><img style="aspect-ratio:619/54;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_22_at_1_28_06_AM_png_bc045b5c79.webp" alt="Screenshot 2025-08-22 at 1.28.06 AM.png" width="619" height="54"><figcaption>EW sentiment and message volume as of 1:30 a.m. ET, Aug. 22 | source: Stocktwits</figcaption></figure>For the year-to-date period, the stock has lost about 10%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-on-track-to-extend-drop-on-h20-china-ai-chip-order-halt/chsmnkSRdiv">Nvidia Stock On Track To Extend 3-Day Drop As Chipmaker Reportedly Halts H20 China AI Chip Orders: Retail Traders Turn Anxious</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on July 28, 2025 in New York City.  

vidia continues to make waves and struggling electric-vehicle maker Lucid’s reacted to the news of an imminent reverse stock split.

Citigroup Inc

Lucid Group Inc

AT&T Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$92.01
Prev Close	$94.44
Open	$94.55
Dividend Yield	0.00%
50-Day Moving Average	$88.14
Beta	0.63
Avg. Volume	3.4M
PE Ratio	54.60

52-Week High	$96.29
52-Week Low	$74.66
Market Capitalization	$53.03B
EPS (Annual)	$1.81
Price to Book	5.00
Revenue Per Employee	$379,225.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

EW Fundamentals